S010 Dermatologic Surgery Pearls: Optimizing Safety, Satisfaction, Efficiency
DESCRIPTION
This session will recognize opportunities to enhance the overall dermatologic surgery practice by highlighting pearls to improve patient safety and satisfaction. Discussions will also focus on physician safety and tips on optimizing efficiency in the surgical setting.
LEARNING OBJECTIVES
Discuss pearls to optimize patient and physician safety while maximizing efficiency in the dermatologic surgery clinical practice.
Discuss strategies to improve patient experience and satisfaction.
SCHEDULE
1:00 PM
Nail Surgery
Kishwer S. Nehal, MD, FAAD
1:16 PM
Dermpath Pearls for Derm Surgeons
Ashley Nicole Elsensohn, MD, MPH, FAAD
1:48 PM
Managing wound healing/pain in Hidradenitis suppurativa surgery
Iltefat H. Hamzavi, MD, FAAD
1:50 PM
Q&A
Kishwer S. Nehal, MD, FAAD, Ashley Nicole Elsensohn, MD, MPH, FAAD, Iltefat H. Hamzavi, MD, FAAD
2:00 PM
Managing Challenging Surgical Wounds
Sumaira Zareen Aasi, MD, FAAD
2:16 PM
Photography/biopsy site identification
Cristian Navarrete-Dechent, MD, IFAAD
2:32 PM
Practical Apps & Tools
2:50 PM
Q&A
Sumaira Zareen Aasi, MD, FAAD, Cristian Navarrete-Dechent, MD, IFAAD
3:00 PM
Wellness & Ergonomics
3:16 PM
Reducing risk of Surgical Injuries
Rachel Rigo, MD, FAAD
3:32 PM
Pre op cautionary tales
Megan H. Trager, MD, FAAD
3:50 PM
Q&A
Rachel Rigo, MD, FAAD, Megan H. Trager, MD, FAAD
DIRECTOR
Kishwer S. Nehal, MD, FAAD
SPEAKERS
Sumaira Zareen Aasi, MD, FAAD
Ashley Nicole Elsensohn, MD, MPH, FAAD
Loma Linda University
Iltefat H. Hamzavi, MD, FAAD
Cristian Navarrete-Dechent, MD, IFAAD
Pontificia Universidad Catolica de Chile
Rachel Rigo, MD, FAAD
Megan H. Trager, MD, FAAD
DISCLOSURES
Sumaira Zareen Aasi, MD, FAAD
No financial relationships exist with ineligible companies.
Ashley Nicole Elsensohn, MD, MPH, FAAD
No financial relationships exist with ineligible companies.
Iltefat H. Hamzavi, MD, FAAD
AbbVie – Advisory Board(Fees); Almirall – Consultant (1099 relationship)(Fees); Avita – Investigator(Grants/Research Funding); Beiersdorf, Inc. – Advisory Board(Fees); Boehringer Ingelheim – Consultant(Fees); Clinuvel – Investigator(Fees); Galderma Laboratories, L.P. – Investigator(Fees); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Hidradenitis Suppurativa Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Investigator(Grants/Research Funding); Janssen Biotech – Investigator(Grants/Research Funding); L'Oreal USA Inc. – Investigator(Grants/Research Funding); Lenicura – Investigator(Equipment); Merck – Investigator(Grants/Research Funding); MyDerm Portal, Inc – Stockholder(Stock); Novartis – Consultant(Fees); Pfizer Inc. – Investigator(Fees); Sonoma Biotherapeutics – Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); Teva Pharmaceutical Industries Ltd. – Investigator(Fees); UCB – Consultant(Fees); Vimela – Consultant (1099 relationship)(Fees);
Cristian Navarrete-Dechent, MD, IFAAD
No financial relationships exist with ineligible companies.
Kishwer S. Nehal, MD, FAAD
No financial relationships exist with ineligible companies.
Rachel Rigo, MD, FAAD
No financial relationships exist with ineligible companies.
Megan H. Trager, MD, FAAD
No financial relationships exist with ineligible companies.